Aligos Therapeutics Inc. (ALGS) Begins First Cohort Dosing in Ongoing Phase 1 PoC Study Evaluating ALG-000184
Go back to Aligos Therapeutics Inc. (ALGS) Begins First Cohort Dosing in Ongoing Phase 1 PoC Study Evaluating ALG-000184(NASDAQ: ALGS) | Delayed: 0.98 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $0.98 | 52 Week High | $ | |||
Open | $0.98 | 52 Week Low | $ | |||
Day High | $0.98 | P/E | N/A | |||
Day Low | $0.98 | EPS | $ | |||
Volume | 5,326 |